Leandro S. D’Abronzo

1.0k total citations
28 papers, 516 citations indexed

About

Leandro S. D’Abronzo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Leandro S. D’Abronzo has authored 28 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Leandro S. D’Abronzo's work include Prostate Cancer Treatment and Research (17 papers), Cancer-related gene regulation (5 papers) and PARP inhibition in cancer therapy (5 papers). Leandro S. D’Abronzo is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Cancer-related gene regulation (5 papers) and PARP inhibition in cancer therapy (5 papers). Leandro S. D’Abronzo collaborates with scholars based in United States, Germany and France. Leandro S. D’Abronzo's co-authors include P. Ghosh, Inge Werner, Richard E. Connon, Alan P. Lombard, Christopher P. Evans, Allen C. Gao, Wei Lou, Cameron M. Armstrong, Chengfei Liu and Joy C. Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Leandro S. D’Abronzo

27 papers receiving 515 citations

Peers

Leandro S. D’Abronzo
Sean M. Courtney United States
Matthew S. Loftus United States
Martino Monteverde Italy
Gina M. Yanochko United States
Sylvie Veyrenc France
Cheng Zeng China
Mauro Colafranceschi Italy
Lourdes Cruz-Garcia United Kingdom
A.L.G. Schuurmans Netherlands
T. Ishikawa Japan
Sean M. Courtney United States
Leandro S. D’Abronzo
Citations per year, relative to Leandro S. D’Abronzo Leandro S. D’Abronzo (= 1×) peers Sean M. Courtney

Countries citing papers authored by Leandro S. D’Abronzo

Since Specialization
Citations

This map shows the geographic impact of Leandro S. D’Abronzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leandro S. D’Abronzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leandro S. D’Abronzo more than expected).

Fields of papers citing papers by Leandro S. D’Abronzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leandro S. D’Abronzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leandro S. D’Abronzo. The network helps show where Leandro S. D’Abronzo may publish in the future.

Co-authorship network of co-authors of Leandro S. D’Abronzo

This figure shows the co-authorship network connecting the top 25 collaborators of Leandro S. D’Abronzo. A scholar is included among the top collaborators of Leandro S. D’Abronzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leandro S. D’Abronzo. Leandro S. D’Abronzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Shu, Cameron M. Armstrong, Leandro S. D’Abronzo, et al.. (2024). IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer. iScience. 27(2). 108984–108984. 6 indexed citations
2.
Siddiqui, Salma, Christiana Drake, Benjamin A. Mooso, et al.. (2023). Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase. Journal of Biological Chemistry. 299(8). 104973–104973. 4 indexed citations
3.
Ning, Shu, Chengfei Liu, Wei Lou, et al.. (2022). Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Molecular Cancer Therapeutics. 21(10). 1594–1607. 16 indexed citations
4.
Lombard, Alan P., Cameron M. Armstrong, Leandro S. D’Abronzo, et al.. (2022). Olaparib-Induced Senescence Is Bypassed through G2–M Checkpoint Override in Olaparib-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 21(4). 677–685. 14 indexed citations
5.
Ning, Shu, Jinge Zhao, Alan P. Lombard, et al.. (2022). Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes. SHILAP Revista de lepidopterología. 2(1). 118–118. 7 indexed citations
6.
Liu, Chengfei, Wei Lou, Alan P. Lombard, et al.. (2022). PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER. The Journal of Urology. 207(Supplement 5). 1 indexed citations
7.
Lombard, Alan P., Wei Lou, Cameron M. Armstrong, et al.. (2021). Activation of the ABCB1 Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells. Molecular Cancer Therapeutics. 20(10). 2061–2070. 13 indexed citations
8.
Armstrong, Cameron M., Chengfei Liu, Liangren Liu, et al.. (2020). Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer. Clinical Cancer Research. 26(22). 6064–6074. 17 indexed citations
9.
Liu, Chengfei, Joy C. Yang, Cameron M. Armstrong, et al.. (2019). AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics. 18(10). 1875–1886. 53 indexed citations
10.
Lombard, Alan P., Chengfei Liu, Cameron M. Armstrong, et al.. (2019). Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer. Translational Oncology. 12(7). 871–878. 23 indexed citations
11.
Siddiqui, Salma, Benjamin A. Mooso, Leandro S. D’Abronzo, et al.. (2019). Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase. British Journal of Cancer. 121(3). 237–248. 20 indexed citations
12.
Lombard, Alan P., Chengfei Liu, Cameron M. Armstrong, et al.. (2019). Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells.. PubMed. 7(4). 203–214. 11 indexed citations
13.
D’Abronzo, Leandro S. & P. Ghosh. (2018). eIF4E Phosphorylation in Prostate Cancer. Neoplasia. 20(6). 563–573. 40 indexed citations
14.
D’Abronzo, Leandro S., Chong-xian Pan, & P. Ghosh. (2017). Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum. Methods in molecular biology. 1655. 319–334. 4 indexed citations
15.
D’Abronzo, Leandro S., Swagata Bose, Ruth L. Vinall, et al.. (2017). The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 36(46). 6359–6373. 35 indexed citations
16.
Chen, Liqun, Salma Siddiqui, Blythe Durbin‐Johnson, et al.. (2015). Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocrine Related Cancer. 22(3). 369–386. 17 indexed citations
17.
Durieux, Éric, et al.. (2012). Cytochrome P4501A mRNA and protein induction in striped bass (Morone saxatilis). Fish Physiology and Biochemistry. 38(4). 1107–1116. 8 indexed citations
18.
Pan, Chong-xian, et al.. (2012). Abstract 5750: Synergistic effects of everolimus and bicalutamide in castration-resistant prostate cancer: Results from a phase I/II clinical trial. Cancer Research. 72(8_Supplement). 5750–5750. 2 indexed citations
19.
Connon, Richard E., et al.. (2011). Sublethal responses to ammonia exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae). Aquatic Toxicology. 105(3-4). 369–377. 29 indexed citations
20.
Connon, Richard E., Juergen Geist, Janice Pfeiff, et al.. (2009). Linking mechanistic and behavioral responses to sublethal esfenvalerate exposure in the endangered delta smelt; Hypomesus transpacificus (Fam. Osmeridae). BMC Genomics. 10(1). 608–608. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sean M. Courtney Breakdown of academic impact, for papers by Matthew S. Loftus Breakdown of academic impact, for papers by Martino Monteverde Breakdown of academic impact, for papers by Gina M. Yanochko Breakdown of academic impact, for papers by Sylvie Veyrenc Breakdown of academic impact, for papers by Cheng Zeng Breakdown of academic impact, for papers by Mauro Colafranceschi Breakdown of academic impact, for papers by Lourdes Cruz-Garcia Breakdown of academic impact, for papers by A.L.G. Schuurmans Breakdown of academic impact, for papers by T. Ishikawa
Rankless by CCL
2026